Navigation Links
Will new drugs block hepatitis C virus in its tracks?
Date:6/28/2011

Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.

The study by Dr Stephen Griffin and colleagues, published in the journal Hepatology, reveals how two prototype small molecule drugs, known as p7 inhibitors, can each attack different parts of the hepatitis C virus. Their findings suggest that p7 inhibitors could be a powerful way of suppressing hepatitis C, when used together with the latest generation of 'direct-acting' drugs.

More than 170 million people - or 3% of the world's population - are infected with the hepatitis C virus. The virus causes severe liver disease and is a leading cause of liver-related deaths, organ transplants and liver cancer.

At the moment, patients are typically treated with PEGylated interferon alpha (IFN) and ribavirin (Rib) - drugs that work by boosting the patient's immune system. However, the effects of these drugs can depend on the individual patient's genetic make-up. To make matters worse, hepatitis C is often resistant to the therapy and fails to suppress the virus for long enough. The treatment is also expensive and can trigger unpleasant side effects. Many patients stop taking the drugs or do not take them when they should.

To address this, researchers are looking at new classes of drugs that work in a different way to either IFN or Rib and target the virus directly. The aim is to find groups of these 'direct-acting' drugs that each attack a different target, making it much, much harder for the virus to fight back.

University of Leeds researchers are focusing on drugs that target the p7 ion channel - a protein made by hepatitis C that allows the virus to continue spreading. In previous studies, Dr Griffin and colleagues worked out how the p7 ion channel could be blocked by certain types of small molecule, stopping the hepatitis C virus in its tr
'/>"/>

Contact: Paula Gould
p.a.gould@leeds.ac.uk
44-113-343-8059
University of Leeds
Source:Eurekalert

Page: 1 2

Related biology news :

1. Premature aging caused by some HIV drugs, study shows
2. Elsevier launches International Journal for Parasitology: Drugs and Drug Resistance
3. Drugs from the sea: New discoveries in marine biomedicine
4. Yale researchers explain why cancer smart drugs may not be so smart
5. System in brain -- target of class of diabetes drugs -- linked to weight gain
6. NIH researchers create comprehensive collection of approved drugs to identify new therapies
7. Experimental Alzheimers disease drugs might help patients with nerve injuries
8. New technique tracks viral infections, aids development of antiviral drugs
9. New device promises safer way to deliver powerful drugs
10. New strategy for stimulating neurogenesis may lead to drugs to improve cognition and mood
11. Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... R.I. [Brown University] In a brief paper in ... a new, freely available Web-based program called Spliceman for ... splicing of messenger RNA, potentially leading to disease. ... mutations and computes how likely these single nucleotide variants ...
... is key to addressing the major challenges facing humanity in ... Frommer. In a Perspective published in The Plant Cell ... technology is key to transforming plant biology in order to ... of energy into the biosphere, provide food and materials used ...
... cardiac pacemakers turns to an unlikely source: vibrations from ... of Michigan designed a device that harvests energy from ... it to electricity to run a pacemaker or an ... the heart to keep it beating in a healthy ...
Cached Biology News:Will a genetic mutation cause trouble? Ask Spliceman 2The future of plant science a technology perspective 2Heart-powered pacemaker could one day eliminate battery-replacement surgery 2
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol ... premium industry insights on the global resorcinol industry. The report highlights the various ... vivid market scenarios and analysis of primary and secondary inputs from the existing ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, ... as Sales & Marketing Director. , With more than 25 years of ... for reinforcing Tronics’ business development activities worldwide. He brings to the company his ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... AUSTIN, Texas , Feb. 15 Dr. Robert Johnson ... at the 5th Annual Stem Cell Summit in New York ... most recent data proving the efficacy of point of care adult stem ... own cells derived from bone marrow to inhibit bone growth in spinal ...
... the Nano/Bio Interface Center of the University of ... to electrical current in a molecular circuit. The ... respond to electromagnetic waves by creating surface plasmons ... similar to that of photovoltaic solar cells. ...
... ... DNalysis have successfully rolled out PatentSafe, protecting their forensic results and allowing their scientists ... ... 2010 -- Amphora Research Systems is pleased to announce that DNalysis have implemented PatentSafe ...
Cached Biology Technology:SpineSmith to Present at the 5th Annual Stem Cell Summit 2SpineSmith to Present at the 5th Annual Stem Cell Summit 3Penn material scientists turn light into electrical current using a golden nanoscale system 2Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 2Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 3
... is primarily used for the preparation of ... for tracing. NH2-Reactive B-Phycoerythrin, a component of ... can easily make a covalent bond with ... without any activation process. Filtration Tube included ...
Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
Mouse monoclonal antibody raised against a partial recombinant KRT4. NCBI Entrez Gene ID = KRT4...
Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
Biology Products: